ResearcherFudan UniversityActive in the last 2 years

Na Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0403-0111; OpenAlex author ID A5100385282. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes. Co-author DOI 10.1007/s00535-024-02204-w ↗
S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41419-022-05004-3 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaomu Li · 1 shared paper, 2025 · strength 0.26
- Paper Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes. DOI 10.1007/s00535-024-02204-w ↗
Ke Hu · 1 shared paper, 2025 · strength 0.26
- Paper Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes. DOI 10.1007/s00535-024-02204-w ↗
Yuan Ji Ma · 1 shared paper, 2025 · strength 0.26
- Paper Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes. DOI 10.1007/s00535-024-02204-w ↗
Wenchuan Wu · 1 shared paper, 2025 · strength 0.26
- Paper Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes. DOI 10.1007/s00535-024-02204-w ↗
Xue Qiang Zeng · 1 shared paper, 2022 · strength 0.16
- Paper S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarc… DOI 10.1038/s41419-022-05004-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.